Down-regulation of Akt signaling with HIV-1 protease inhibitors

Down-regulation of Akt signaling with HIV-1 protease inhibitors

Detalles Bibliográficos
Main Authors:	Gupta, A, Cerniglia, G, Mick, R, Mckenna, W, Muschel, R
Formato:	Conference item
Publicado:	2005

Títulos similares

HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo.
por: Gupta, A, et al.
Publicado: (2005)

Phosphorylation of glycogen sythase kinase-3 beta does not contribute to radiation resistance in two cell lines with activation of the Akt pathway
por: Gupta, A, et al.
Publicado: (2004)

The use of signal transduction inhibitors with radiation
por: Mckenna, W, et al.
Publicado: (2006)

Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002.
por: Gupta, A, et al.
Publicado: (2003)

Computational investigations of HIV-1 protease and protease inhibitors interactions
por: Sham, Hoi Fung
Publicado: (2014)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
por: Brunner, T, et al.
Publicado: (2008)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
por: Brunner, T, et al.
Publicado: (2008)

Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.
por: Gupta, A, et al.
Publicado: (2002)

C-Raf-1 protein kinase is not essential for Ras transformation of mouse embryo fibroblasts.
por: Gupta, A, et al.
Publicado: (2003)

Additivity in the Analysis and Design of HIV Protease Inhibitors
por: Jorissen, Robert N., et al.
Publicado: (2012)

Drug Reprofiling to Identify Potential HIV-1 Protease Inhibitors
por: Sunday N. Okafor, et al.
Publicado: (2023-08-01)

Down-Regulation of C1GALT1 Enhances the Progression of Cholangiocarcinoma through Activation of AKT/ERK Signaling Pathways
por: Juthamas Khiaowichit, et al.
Publicado: (2022-01-01)

Farnesyltransferase inhibitors as radiation sensitizers.
por: Mckenna, W, et al.
Publicado: (2002)

Protease nexin 1: a novel regulator of prostate cancer cell growth and neo-angiogenesis.
por: McKee, C, et al.
Publicado: (2013)

Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells.
por: Estefania Alcaraz, et al.
Publicado: (2020-01-01)

FMO-guided design of darunavir analogs as HIV-1 protease inhibitors
por: Hathaichanok Chuntakaruk, et al.
Publicado: (2024-02-01)

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.
por: André, P, et al.
Publicado: (1998)

Signaling pathways in NSCLC as a predictor of outcome and response to therapy.
por: Gupta, A, et al.
Publicado: (2004)

Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS.
por: Cohen-Jonathan, E, et al.
Publicado: (2000)

Live cell imaging reveals distinct roles in cell cycle regulation for Nek2A and Nek2B.
por: Fletcher, L, et al.
Publicado: (2005)

Evaluation of COVID-19 protease and HIV inhibitors interactions
por: Tran Linh, et al.
Publicado: (2022-03-01)

Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.
por: Brunner, T, et al.
Publicado: (2003)

Molecular docking of HIV-1 protease inhibitors using open source software /
por: 368807 Alvin Alexander Idin, et al.
Publicado: (2007)

Design, Synthesis, and Biological Evaluation of Darunavir Analogs as HIV‑1 Protease Inhibitors
por: Muhammad Asad Ur Rehman, et al.
Publicado: (2024-09-01)

Substrate Envelope-Designed Potent HIV-1 Protease Inhibitors to Avoid Drug Resistance
por: Nalam, Madhavi N. L., et al.
Publicado: (2016)

Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma.
por: McKee, C, et al.
Publicado: (2012)

Farnesyltransferase inhibitors as radiation sensitizers.
por: Brunner, T, et al.
Publicado: (2003)

The Ras radiation resistance pathway.
por: Gupta, A, et al.
Publicado: (2001)

Signaling inhibition with radiation in colorectal cancer: clinical trials.
por: Mckenna, W, et al.
Publicado: (2003)

The RAS signal transduction pathway and its role in radiation sensitivity.
por: Mckenna, W, et al.
Publicado: (2003)

Down-Regulation of AKT Signalling by Ursolic Acid Induces Intrinsic Apoptosis and Sensitization to Doxorubicin in Soft Tissue Sarcoma.
por: Victor Hugo Villar, et al.
Publicado: (2016-01-01)

Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1.
por: Xu, D, et al.
Publicado: (2010)

Progress towards the use of HIV protease inhibitors in cancer therapy
por: Bernhard, E, et al.
Publicado: (2008)

Progress towards the use of HIV protease inhibitors in cancer therapy.
por: Bernhard, E, et al.
Publicado: (2008)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
por: V.B. Denisenko, et al.
Publicado: (2010-02-01)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
por: V.B. Denisenko, et al.
Publicado: (2010-02-01)

Susceptibility of HPV-18 Cancer Cells to HIV Protease Inhibitors
por: Lilian Makgoo, et al.
Publicado: (2024-10-01)

Towards the De Novo Design of HIV-1 Protease Inhibitors Based on Natural Products
por: Ana L. Chávez-Hernández, et al.
Publicado: (2021-12-01)

HIV-1 down-regulates the expression of CD1d via Nef.
por: Chen, N, et al.
Publicado: (2006)

Resistance to protease inhibitors and HIV-1 genetic variability in V3 region in people living with HIV/AIDS
por: Maria Eduarda de Sousa Avelino, et al.
Publicado: (2024-09-01)